Former Quintiles and Glaxo Executive, Santo J. Costa, Joins Dermatrends Board of Directors.To download high-resolution, print-ready JPEG JPEG
in full Joint Photographic Experts Group
Standard computer file format for storing graphic images in a compressed form for general use. JPEG images are compressed using a mathematical algorithm. images, click on the thumbnail image above.
WARNING: these images are
very large (800K+)
Click here for caption
Photo Editors/Business Editors/Health/Medical Writers
MINNEAPOLIS--(BUSINESS WIRE)--May 10, 2004
Dermatrends, Inc., a privately held research and development company devoted to transdermal and other drug delivery technologies, has strengthened its board of directors with the addition of Santo J. (Sandy) Costa, former president and chief operating officer Chief Operating Officer (COO)
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of Quintiles Quintiles Transnational Corp. is a contract research organization which serves the pharmaceutical, biotechnology and healthcare industries. History
Quintiles was founded in 1982 by Dennis Gillings and as of 2007 it has 18,000 employees. Transnational Corporation Any corporation that is registered and operates in more than one country at a time; also called a multinational corporation.
A transnational, or multinational, corporation has its headquarters in one country and operates wholly or partially owned subsidiaries in one or more and a consultant to A.M. Pappas & Associates, a leading venture capital and consulting firm serving the life sciences industry.
"Mr. Costa has been a great advisor to Dermatrends in the past," said Ted Schwarzrock, Dermatrends chairman, president and chief executive officer. "We are very excited to have him deepen his commitment to our success by joining our board of directors. The rest of the board and I believe that his broad experience in the pharmaceutical industry will be invaluable for Dermatrends moving forward."
Mr. Costa joined Quintiles Transnational Corp. in April 1994. During his six year tenure as president and chief operating officer, Quintiles transformed itself from a contract research organization into a fully integrated global service company. Annual revenue grew at a compound annual rate of 80 percent, rising from $90 million to $1.6 billion, with net income rising from $6.7 million to $109 million. Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Headquartered near Research Triangle Park Research Triangle Park, research, business, medical, and educational complex situated in central North Carolina. It has an area of 6,900 acres (2,795 hectares) and is 8 × 2 mi (13 × 3 km) in size. Named for the triangle formed by Duke Univ. , North Carolina North Carolina, state in the SE United States. It is bordered by the Atlantic Ocean (E), South Carolina and Georgia (S), Tennessee (W), and Virginia (N). Facts and Figures
Area, 52,586 sq mi (136,198 sq km). Pop. , Quintiles is a member of the S&P 500 and Fortune 1000.
Mr. Costa began his career as food and drug counsel for Norwich/Eaton Pharmaceuticals. Before joining Quintiles, he spent 23 years in the pharmaceutical industry, eventually serving as senior vice president and general counsel of Glaxo Inc. GlaxoSmithKline, one of the world's leading research-base pharmaceutical and healthcare companies, is committed to improving the quality of human life by enabling people to do more, feel better and live longer. Mr. Costa sat on the Glaxo's board of directors and was deeply involved in managing the company's growth from $600 million in annual revenues in 1986 to nearly $3 billion in annual revenues in 1993. Prior to joining Glaxo, Mr. Costa was U.S. area counsel for Merrell Dow Pharmaceuticals.
Mr. Costa is on the board of advisors at A. M. Pappas & Associates, a leading venture capital firm focused on the medical and biotechnology industries. He also sits on the Board of Directors of NPS NPS National Park Service
NPS Naval Postgraduate School
NPS Net Promoter Score (customer management)
NPS Non-Point Source pollution
NPS Native Plant Society
NPS Norfolk Public Schools (Virginia) Pharmaceuticals, C V Therapeutics, Ribapharm, DigiScripts and Yonkers Industries and serves as an adjunct professor in the clinical research program at the Campbell University School of Pharmacy The Campbell University School of Pharmacy is an American pharmacy school founded in 1985 and located in Buies Creek, North Carolina. The Pharmacy School is one of six schools that compose Campbell University. , where he has lectured on food and drug law along with a wide variety of other issues affecting the pharmaceutical industry.
He also sits on the board of directors of The Duke Medical Center Children's Classic and the North Carolina Outward Bound School, the Duke Brain Tumor Brain Tumor Definition
A brain tumor is an abnormal growth of tissue in the brain. Unlike other tumors, brain tumors spread by local extension and rarely metastasize (spread) outside the brain. Advisory Committee, the Duke University Medical Center Board of Visitors, and the Food and Drug Law Institute Advisory Board. Mr. Costa received his B.S. in pharmacy and his Juris Doctor The degree awarded to an individual upon the successful completion of law school.
Juris doctor, or doctor of Jurisprudence, commonly abbreviated J.D., is the degree commonly conferred by law schools. degrees from St. John's University in 1968 and 1971 respectively. He is married and has three children.
Dermatrends, Inc. is a privately held medical research and development company with business offices in Minneapolis, Minn. and with scientific laboratories in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. . The company is dedicated to the development of proprietary drug delivery technologies and has demonstrated an enabling platform technology that allows a broad variety of ethical and over-the-counter drugs to permeate the skin and mucosal surface at therapeutic levels in excess of anything currently available.
For company information and market development, contact Ted Schwarzrock, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , at 952-920-5383 or contact the company via email at email@example.com.
MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=4636095